In partnership with

7wData Ins7ghts

So, What Actually Happened?

We scanned 190,000 articles this week, and the healthcare AI race just got a serious contender. OpenEvidence doubled its valuation to $12 billion after raising $250 million—positioning itself as the ”ChatGPT for doctors” while Isomorphic Labs struggles to get to clinical trials. Meanwhile, Anthropic rewrote Claude's entire constitutional framework, essentially giving their AI a new ”soul document” that makes it more willing to engage with hard questions. And in a move that signals where the AI value chain is really shifting, Nvidia invested $150 million in Baseten, pushing the inference startup to a $5 billion valuation. The chip giant is betting that the real money isn't in selling hardware—it's in making sure that hardware gets used.

The Bottom Line: Healthcare AI is pulling ahead of drug discovery AI. The model makers are codifying their values. And infrastructure is eating the AI stack from the bottom up.

Help us make better ads

Did you recently see an ad for beehiiv in a newsletter? We’re running a short brand lift survey to understand what’s actually breaking through (and what’s not).

It takes about 20 seconds, the questions are super easy, and your feedback directly helps us improve how we show up in the newsletters you read and love.

If you’ve got a few moments, we’d really appreciate your insight.

The Tracks That Matter

1. OpenEvidence Doubles to $12B: Healthcare AI's Quiet Winner

While Google's Isomorphic Labs delays clinical trials and the AI drug discovery narrative struggles with reality, OpenEvidence just doubled its valuation to $12 billion after raising $250 million. The company, which MobiHealthNews describes as ”ChatGPT for doctors,” is taking a different approach to healthcare AI: instead of trying to discover new drugs, it helps physicians make better decisions with existing knowledge.

The strategic contrast matters. Drug discovery AI requires billions in capital, decade-long timelines, and FDA approvals with uncertain outcomes. Clinical decision support AI can deliver value in months, requires less regulatory burden, and scales across the entire healthcare system. OpenEvidence is betting that the faster path to healthcare AI impact runs through the clinic, not the lab.

Reuters reports the funding comes from top-tier investors who see clinical AI as a less risky bet than the moonshot drug discovery plays. The valuation jump—100% in a single round—suggests they're not alone.

”The biggest economic gains come not from invention alone, but from turning new capabilities into scaled, everyday use.”
— OpenAI (on a related initiative)

Here's what works: If you're evaluating healthcare AI investments or partnerships, look at time-to-value, not just technological ambition. Clinical decision support delivers ROI in quarters; drug discovery delivers it in decades. The market is telling you which bet it prefers right now.

2. Nvidia Bets $150M on Baseten: The Inference Inflection Point

Nvidia just invested $150 million in Baseten as part of a $300 million round that values the AI inference startup at $5 billion. The move signals a strategic shift: Nvidia isn't just selling chips anymore—it's investing in the companies that help enterprises actually use them.

The inference economics are becoming Nvidia's next growth frontier. Training large models requires massive compute clusters, but inference—running models in production—requires a different kind of infrastructure optimized for latency, cost efficiency, and scale. Baseten helps companies deploy and run AI models without building their own inference stack. By investing, Nvidia is making sure the GPU demand doesn't stop at training.

At Davos, Nvidia CEO Jensen Huang dismissed fears of an AI bubble, calling AI ”the single largest infrastructure buildout in human history.” The Baseten investment puts money behind that conviction—Nvidia is betting that AI adoption is still in the early innings and that inference infrastructure will be the next bottleneck.

Here's what works: If you're running AI workloads in production, evaluate specialized inference providers. The total cost of ownership often beats building on raw cloud compute, especially as GPU availability remains constrained. Nvidia's investment validates this market.

Keep pace with your calendar

Dictate investor updates, board notes, and daily rundowns and get final-draft writing you can paste immediately. Wispr Flow preserves nuance and uses voice snippets for repeatable founder comms. Try Wispr Flow for founders.

3. Anthropic Rewrites Claude's Soul Document

Anthropic just published Claude's new constitutional framework—the internal document that shapes how the AI responds to difficult questions about morality, consciousness, and sensitive topics. Fortune reports the rewrite makes Claude more willing to engage with hard questions rather than defaulting to refusal.

The timing is significant. As AI systems become more capable and more integrated into decision-making processes, the values encoded in their training become more consequential. Anthropic is betting that transparency about those values—publishing the document publicly—builds trust with users and differentiates Claude from competitors who keep their guidelines opaque.

The constitutional approach represents a middle path between ”safety through restriction” and ”safety through capability.” Rather than simply blocking categories of responses, Claude's constitution attempts to instill principles that guide reasoning. Whether this approach actually produces safer AI remains contested, but it's now the most visible experiment in AI values engineering.

Here's what works: When evaluating AI vendors for enterprise use, ask about their value alignment frameworks. Not just content policies, but the underlying principles that shape how the AI reasons. Anthropic's transparency sets a benchmark—if your vendor can't articulate their approach, they may not have one.

4. The Otter.ai Lawsuit: AI Note-Takers Face Legal Reckoning

A class action lawsuit against Otter.ai highlights a growing legal and privacy concern: AI note-taking tools that record, transcribe, and analyze workplace conversations without clear consent frameworks. The lawsuit, filed in U.S. District Court for the Northern District of California, alleges violations of privacy rights when AI systems capture conversations without adequate disclosure.

The case represents a broader regulatory flashpoint. AI tools that passively monitor workplace communications—note-takers, email assistants, meeting summarizers—operate in a legal gray zone. Employment law, privacy regulations, and AI governance frameworks are colliding, and enterprises deploying these tools face growing compliance exposure.

The regulatory outlook for 2026 makes this even more urgent. Expect litigation over preemption scope, increased federal enforcement, and new state AI laws. Colorado's Anti-Discrimination in AI Law takes effect in June 2026. The compliance environment is becoming more contested, not less.

”2026 is poised to be the year that conflict materializes in earnest.”
— Legal analysis on AI regulation

Here's what works: Audit your workplace AI tools for consent and disclosure practices. If you're using AI note-takers, meeting assistants, or communication analyzers, review the legal basis for data collection. The Otter.ai lawsuit won't be the last—and proactive compliance is cheaper than reactive litigation.

5. Gates Foundation and OpenAI Launch $50M Healthcare Initiative in Africa

Bill Gates unveiled the Horizon 1000 initiative in partnership with OpenAI—a $50 million effort to deploy AI-powered primary healthcare tools across Africa. The timing isn't accidental: the initiative arrives as global health aid faces cuts and emerging markets need scalable healthcare solutions.

OpenAI's announcement positions Horizon 1000 as more than philanthropy—it's a proof-of-concept for AI in low-resource healthcare settings. The initiative will deploy AI assistants to support community health workers, helping them diagnose, triage, and refer patients in areas where doctors are scarce.

The Gates Foundation angle matters strategically. This isn't OpenAI dabbling in healthcare; it's a structured partnership with the world's most experienced global health funder. If Horizon 1000 succeeds, it validates AI healthcare deployment models that could scale across emerging markets—a potential growth vector far larger than developed market enterprise sales.

Here's what works: Watch Horizon 1000 as a leading indicator for AI healthcare scalability. If AI can deliver value in resource-constrained African clinics, the deployment playbook will transfer to other underserved markets. The technology that works at the edge usually works everywhere.

6. GoodData Launches MCP Server: Analytics Infrastructure Gets AI-Native

GoodData just launched a Model Context Protocol (MCP) server, enabling AI tools to directly access and execute analytics workflows. The significance: AI is moving from ”read-only”—answering questions about data—to ”read-write”—actually manipulating analytics pipelines and generating insights autonomously.

The MCP protocol is becoming table stakes. AWS, Microsoft, Databricks, Snowflake, and Teradata have all added MCP support. Analytics vendors without MCP capabilities risk being invisible to AI agents, which increasingly mediate how users interact with data platforms.

GoodData's approach stands out by exposing governed analytics logic as executable infrastructure. Rather than just letting AI query data, the MCP server lets AI understand how the analytics layer works—semantic models, business rules, and governance constraints—and operate within those boundaries.

”MCP servers rapidly becoming table stakes for analytic platform providers.”
— Industry analyst

Here's what works: If your analytics stack doesn't support MCP, start planning. AI-native interfaces will increasingly be how users access data—through agents and assistants, not dashboards. The platforms that are AI-accessible will win the attention of the next generation of data users.

7. Datarails Raises $70M: The CFO's AI Moment Arrives

Datarails just raised $70 million to inject AI into Excel-based finance workflows. The funding round, led by One Peak, validates a thesis that's been building for years: the CFO office is the next enterprise AI frontier, and the path to adoption runs through Excel, not against it.

The strategic insight matters. Rather than trying to replace Excel—a 40-year losing battle—Datarails augments it. Financial planning and analysis (FP&A) teams that live in spreadsheets can add AI capabilities without abandoning their workflows. This dramatically lowers adoption friction.

FinancialIT reports that Datarails sees itself as making AI ”the foundation for the CFO's office.” The playbook: don't disrupt existing workflows; enhance them. Don't ask finance teams to learn new tools; bring AI to the tools they already use.

Here's what works: If you're planning AI deployments in finance, map to existing workflows before proposing new tools. The Datarails funding validates an approach that meets users where they are. Excel isn't going anywhere—but AI-augmented Excel changes what finance teams can do.

But what can you actually DO about the proclaimed ‘AI bubble’? Billionaires know an alternative…

Sure, if you held your stocks since the dotcom bubble, you would’ve been up—eventually. But three years after the dot-com bust the S&P 500 was still far down from its peak. So, how else can you invest when almost every market is tied to stocks?

Lo and behold, billionaires have an alternative way to diversify: allocate to a physical asset class that outpaced the S&P by 15% from 1995 to 2025, with almost no correlation to equities. It’s part of a massive global market, long leveraged by the ultra-wealthy (Bezos, Gates, Rockefellers etc).

Contemporary and post-war art.

Masterworks lets you invest in multimillion-dollar artworks featuring legends like Banksy, Basquiat, and Picasso—without needing millions. Over 70,000 members have together invested more than $1.2 billion across over 500 artworks. So far, 25 sales have delivered net annualized returns like 14.6%, 17.6%, and 17.8%.*

Want access?

Investing involves risk. Past performance not indicative of future returns. Reg A disclosures at masterworks.com/cd

Signal vs. Noise

🟢 Signal: Claude's PageRank grew 33% this week while Demis Hassabis mentions spiked 500%. When Anthropic publishes transparency documents and DeepMind's CEO dominates AI discourse, it signals the conversation is shifting from ”what can AI do” to ”what should AI do.” The values layer is becoming a competitive differentiator.

🔴 Noise: The ”AI will replace X” headlines continue at high volume but declining influence. Our PageRank analysis shows these stories get mentions but don't drive structural importance in the knowledge graph. The market has moved past fear-driven narratives to practical adoption questions.

From the 190K

We scanned 190,000 articles this week. Here's what no one's talking about:

The Infrastructure Divergence Pattern

Three funding rounds this week tell the same story from different angles: Nvidia invests in Baseten (inference), Datarails raises for CFO tools (workflow infrastructure), and Upscale AI raises $200 million to build scale-up networks for AI systems.

The pattern: AI investment is bifurcating. One track funds model capabilities (bigger, smarter, more powerful). The other track funds the infrastructure that makes AI usable—inference optimization, workflow integration, networking for AI clusters. The infrastructure track is where the smart money is quietly positioning.

This echoes the cloud computing playbook. The companies that won the cloud era weren't just the ones with the best technology; they were the ones with the best infrastructure for making that technology accessible. The AI infrastructure buildout is following the same pattern, just faster.

🔍 Below the surface: MCP protocol mentions appeared in 47 articles this week but made zero mainstream headlines. Here's how you spot real infrastructure: when something shows up everywhere but headlines nowhere, it means engineers are adopting it while marketing hasn't caught up. GoodData, Databricks, Snowflake, and a dozen others are racing to add MCP support. The protocol layer that AI agents will use to interact with enterprise data is being standardized now—and most executives don't even know it exists.

By The Numbers

  • $12B — OpenEvidence's valuation after $250M raise, doubling from the previous round
  • $5B — Baseten's valuation after $300M round with Nvidia's $150M investment
  • $70M — Datarails Series C to bring AI to CFO's Excel workflows
  • $50M — Gates Foundation/OpenAI Horizon 1000 healthcare initiative for Africa
  • 149 — GDPR mentions this week, up from 119 last week
  • +99% — Anthropic's PageRank growth as constitutional AI gains attention
  • +191% — Cybersecurity's PageRank growth, reflecting rising enterprise concern

Deep Dive: When AI Gets a Soul Document

Like a DJ who finally writes down the philosophy behind why certain tracks get mixed together, Anthropic just codified the values that shape how Claude thinks. The implications ripple further than one company's product update.

The Constitutional Approach

Anthropic's ”constitutional AI” framework represents a bet that AI safety isn't just about restriction—it's about instilling principles. Rather than simply blocking categories of harmful content, Claude's constitution attempts to give the AI a framework for moral reasoning. It's the difference between a fence and a compass.

The published document makes Claude more transparent than competitors. When users wonder why Claude responds a certain way, they can reference the actual principles. Whether transparency builds trust or creates attack vectors for manipulation remains an open question.

The Competitive Implications

OpenAI keeps GPT's guidelines largely opaque. Google's Gemini policies are evolving but not fully public. By publishing Claude's constitution, Anthropic is making transparency a competitive differentiator. Enterprise customers increasingly want to understand the AI systems they're deploying—and ”we published our values” is a more satisfying answer than ”trust us.”

The Deeper Question

If AI systems are going to make consequential decisions—hiring recommendations, healthcare guidance, financial advice—who decides what values they embody? Anthropic's constitution is one answer: the company decides, but shows its work. Other answers are possible: user customization, regulatory requirements, democratic deliberation. The constitutional AI approach is an experiment in AI governance, not a final answer.

What Actually Works

  1. Audit AI vendors for transparency: Can they articulate the principles that guide their AI's responses? If not, you're trusting a black box.

  2. Map constitutional alignment to use cases: Claude's principles may fit some enterprise applications better than others. Understand what you're buying.

  3. Anticipate regulatory requirements: AI value frameworks will likely become compliance requirements. The companies building transparency now will be ahead of mandates later.

  4. Watch for weaponization: Published principles can be reverse-engineered for manipulation. The cat-and-mouse game between safety frameworks and adversarial attacks is just beginning.

The question isn't whether AI needs values—it's who gets to define them and how transparent that process should be. Anthropic just placed a bet on openness. The industry is watching to see if it pays off.

What's Coming

AI Regulation Flashpoint in 2026

Legal analysis suggests 2026 will feature litigation over federal preemption scope, increased enforcement actions, and continued state innovation in AI governance. Colorado's Anti-Discrimination in AI Law takes effect in June. Build regulatory flexibility into your AI deployments.

Inference Infrastructure Investment Wave

The Nvidia/Baseten deal signals where smart money is heading. Expect more AI infrastructure startups to raise at elevated valuations as enterprises struggle to deploy models in production. The inference bottleneck is becoming as important as the training compute bottleneck was two years ago.

Healthcare AI Splits from Drug Discovery AI

OpenEvidence's $12 billion valuation versus Isomorphic Labs' delayed timelines suggests the market is differentiating between healthcare AI categories. Clinical decision support AI (faster deployment, clearer ROI) is separating from drug discovery AI (longer timelines, higher risk). Watch for more investment divergence.

For Your Team

Thursday's meeting prompt: ”Anthropic just published Claude's constitutional framework—the values document that shapes how the AI reasons. Do we know what values are encoded in the AI systems we're deploying? And if we had to publish our AI's 'constitution,' what would it say?”

The AI Values Transparency Framework:

  1. Audit your AI vendors — Can they explain the principles guiding their AI's behavior, or is it a black box?
  2. Map values to use cases — Different AI applications may need different value frameworks. Hiring AI shouldn't reason like customer service AI.
  3. Prepare for mandates — AI value transparency will likely become regulatory requirement. Get ahead of compliance.
  4. Consider your own constitution — If you're building AI-enhanced products, what values should they embody? Write it down.

Share-worthy stat: ”OpenEvidence just hit a $12 billion valuation building 'ChatGPT for doctors.' Meanwhile, AI drug discovery timelines keep slipping. The market is telling us which healthcare AI approach it believes in.”

Go deeper: Explore AI value frameworks and enterprise adoption trends →

The Track of the Day

”The biggest economic gains come not from invention alone, but from turning new capabilities into scaled, everyday use.”
— OpenAI, on their education initiative

Like a producer who knows the best track in the world doesn't matter if no one can hear it on their speakers, the AI industry is learning that capability without infrastructure is just a demo. OpenEvidence beat Isomorphic Labs to a $12 billion valuation not by discovering new drugs, but by putting existing knowledge in doctors' hands. Nvidia invested in Baseten not because they need another GPU customer, but because inference infrastructure determines whether GPU investments pay off. The winners of the AI era won't just build the most powerful models—they'll build the infrastructure that makes AI usable. The turntables matter as much as the tracks.

We scanned 190,000 articles this week so you don't have to. Data Pains → Business Gains.

Published: January 22, 2026 | Curated by Yves Mulkers @ Ins7ghts

1,300+ articles scanned. 7 stories selected. Our AI distills the noise into signal—in seconds. Get early access →

Know someone who'd find this useful? Share your unique referral link →

Want Your Own AI Intelligence Briefing?

Our platform analyzes 1,000+ sources daily and delivers personalized insights in seconds.

Join the Waitlist →

Founding members: Lifetime discount • Priority access • Shape the product

How was today's newsletter?

Your feedforward helps us get better and brings you more value

Login or Subscribe to participate

TUNE IN

Don’t like reading, and still want to learn more, we got you hanging….

Tune into our Data Strategy Gurus podcast.

Keep Reading